PGxAI

Curated by Signal

AI-powered platform for analyzing genetic variations in multiple genes involved in drug response

Overview

AI-powered platform for analyzing genetic variations in multiple genes involved in drug response. It provides an in-depth drug interaction analysis, identifying potential risks associated with combined medication intake based on individual genetics.

Key facts

Founded: 2023
Headquarters: Palo Alto, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Healthy Young Minds
Online platform offering personalized child therapy
Health TechnologyVail, United States
PTScout
A billing app with charge capture, ICD auto correct and smooth patient transition
Health TechnologyLecanto, United States
PrimeTime Health Plan
Digital medical plan management platform for individuals
Health TechnologyCanton, United States

About PGxAI

What does PGxAI do?

AI-powered platform for analyzing genetic variations in multiple genes involved in drug response.

Where is PGxAI headquartered?

PGxAI is headquartered in Palo Alto, United States.

When was PGxAI founded?

PGxAI was founded in 2023.

Which sector is PGxAI in?

PGxAI operates in Health Technology.

Who are PGxAI's competitors?

Companies similar to PGxAI include Healthy Young Minds, PTScout, and PrimeTime Health Plan.